Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2011-05-23 Investor Presentation
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
BioEquity Europe 2011Paris, Frankreich
Investor Presentation Classification · 98% confidence The document is a presentation slide deck format, dated May 23, 2011, titled 'Bio€q y uit Europe 2011' and features sections like 'Morp y hoS s at a Glance', pipeline updates (MOR103A, MOR208A, MOR202A), financial guidance tables, and management team details. This structure is characteristic of an Investor Presentation (IP) used to communicate strategy, pipeline progress, and financial outlook to investors, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). It is detailed enough to be an IP but lacks the comprehensive structure of an Annual Report (10-K) or a formal Interim Report (IR).
2011-05-23 English
German & Austrian Corporate Conference 2011 Frankfurt, Deutschland
Investor Presentation Classification · 98% confidence The document is titled 'Deutsche Bank –German & Austrian Corporate Conference 2011' and contains slides detailing a company's (MorphoSys) pipeline, technology, financial guidance, management team, and future newsflow. This structure, featuring slides with key data points, pipeline updates, and financial tables presented at a conference, is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), nor is it a transcript of a call (CT). It is a presentation designed for investors.
2011-05-20 English
AGM Information 2011
AGM Information Classification · 99% confidence The document text explicitly states: '**MorphoSys AG Annual General Meeting on May 19, 2010**' and the content is structured as a presentation with slides, including a 'Report of the Management Board' and an agenda typical of a shareholder meeting. The speakers are the Chairman and CFO presenting operational and financial reviews for the previous year (2010). This content perfectly matches the definition of materials shared during an Annual General Meeting (AGM). Although it contains financial review elements, the context is the meeting itself, not a standalone financial report (10-K or IR).
2011-05-19 English
Investor Presentation 2011
Investor Presentation Classification · 99% confidence The document text is structured as a presentation, indicated by the use of 'Folie' (Slide) headers, speaker introductions ('Redner'), and a clear agenda ('Tagesordnung', 'Agenda'). The content reviews the past year (2010) and provides an outlook, focusing heavily on the drug pipeline, technology (HuCAL, Slonomics), and business segments (AbD Serotec). The opening explicitly states: "MorphoSys AG Ordentliche Hauptversammlung am 19. Mai 2011" (MorphoSys AG Annual General Meeting on May 19, 2011). This content is clearly material presented during an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2011-05-19 German
Annual General Meeting 2011
AGM Information Classification · 98% confidence The document explicitly starts with the title "Annual General Meeting 2011 Agenda" and lists several resolutions typical of an AGM, such as approval of financial statements, appointment of auditors, new election to the Supervisory Board, and resolutions on remuneration and treasury stock. Although it contains a 'Management Report' section and financial data, the primary structure and focus are centered around the items to be voted upon or discussed at the Annual General Meeting. This strongly indicates the document is related to the AGM proceedings or materials. Therefore, the most appropriate classification is AGM Information (AGM-R).
2011-05-19 English
Hauptversammlung 2011
AGM Information Classification · 98% confidence The document text contains German headings such as "Hauptversammlung 2011" (Annual General Meeting 2011), an agenda listing items like "Vorlage des festgestellten Jahresabschlusses" (Submission of the approved annual financial statements), and sections detailing the 2010 financial review ("Rückblick 2010", "Finanzrückblick 2010"). The presence of the AGM agenda items (voting on discharge, auditor election, capital measures) strongly suggests this document is related to the Annual General Meeting. Since it includes the agenda and potentially supporting materials/reports presented at the meeting, the most specific classification is AGM Information (AGM-R). While it contains financial review data, the primary context is the meeting itself, as indicated by the prominent 'Hauptversammlung 2011' title and the agenda structure.
2011-05-19 German

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.